The human gut literally teems with microorganisms from at least 1,000 different species that are increasingly considered to be a valuable resource for the prediction, aetiology and prognosis of disease. Due to continual contact with the environment, primarily via food, the gut is susceptible to infection when a virus, parasite or bacterium enters and disrupts normal gut microbiota (or flora).
'We desperately need a ‘no treatment’ trial for DCIS', says Clive Wells, Chairman of the European Working Group on Breast Cancer Pathology, and London Regional Co-ordinator for the United Kingdom’s National Health Service (NHS) National Breast Cancer Screening Programme. Interview: Frank Swain
The number of cancer patients in Germany continues to rise steadily. An increase in the number of newly diagnosed cases of 14% is expected by 2020 compared to 2008. Therefore early detection is increasingly the focus of attention.
The Starled3 NX is suitable for many applications in the operating theatre and diagnoses in, for example, gynaecology, dermatology and general medicine.
A tiny nanoscale device can accurately measure a patient’s blood for methotrexate – a commonly used but potentially toxic cancer drug – in under 60 seconds, according to biomedical instrument designer Jean-François Masson, and Joelle Pelletier, a DHFR enzyme specialist, both at the Chemistry Department, University of Montreal.
Accident and Emergency (A&E) teams play a key role in identifying patients with sepsis, followed by risk stratification for severe sepsis and septic shock, initiating resuscitation and treatment, and ensuring the correct onward management of patients identified with sepsis. Report: Mark Nicholls
Founded in Germany 25 years ago, EKF Diagnostics’ PLC HQ is currently in Cardiff, Wales, where the firm is pursuing the development of a molecular assay for specific cancer types.
UK scientists are developing a hand-held testing device for use at the point of care and provide a disease diagnosis on the same day.
Frost & Sullivan Life Sciences Senior Research Analyst Sriram Radhakrishnan discusses the available screening options to enable early detection of the virus.
For several decades pathologists worldwide have been under increasing pressure to handle a steady increase in laboratory tests with a steady decrease in finance and staff.
Agfa HealthCare announces today that it has signed an agreement with Real Time Medical (RTM) to support the needs of collaborating or consolidated hospitals and imaging networks.
Having convinced medical labs across Denmark that its suite of image analysis software can provide a solution to the crushing burden of in vitro diagnostics (IVD), VisioPharm is offering it to pathologists worldwide
This April, in San Jose, California, the portable lab took central stage at the American Association for Clinical Chemistry’s (AACC) annual forum for emerging clinical diagnostic technologies – a most appropriate topic for the Silicon Valley venue where so many world-changing computer and communications innovations have been born.
Future of DNA sequencing will shift from a laboratory-based setup to point of care testing in the next 5 years
Nothing is more personal than a scan of the insides of your body. Yet radiology images today look a little old-fashioned and out-of-step in the fast-emerging movement to personalised medicine.
Today is World Cancer Day 2014 and COCIR wants to take this opportunity to raise awareness of what our sector (medical imaging and health ICT) is contributing to the fight against cancer, by providing solutions for the prevention, early diagnosis and treatment of this devastating, ever-rising chronic disease.
Offering attractive procurement strategies will boost adoption of high-end tools
Considering ambient lighting conditions, quality assurance of medical displays requires new standards. As a result of the development in medical imaging over the past 20 years, digital medical imaging has replaced the conventional film imaging in most hospitals.
Cooperation between the individual diagnostic fields of radiology, pathology and laboratory medicine has increased in daily clinical routine over the last few years. To a large extent, the three disciplines are faced with the same requirements and problems.
Medicine is not immune to prejudices. In the past, the ‘fatty liver’ diagnosis was often accompanied by the hasty conclusion that the problem was surely caused by alcohol abuse.
Israel - Researchers are using breath-test technology to detect volatile organic compounds to tell whether a patient has stomach cancer.
Urgent action is needed to improve the diagnosis and management of CDI, which is the main cause of hospital-acquired (nosocomial) diarrhoea in industrialised countries. In a report launched today, during a meeting hosted by the European Healthcare and Hospital Federation (HOPE), experts from across Europe highlight the current deficiencies in the management of CDI and outline the steps that are…
A hospital is not the best place to get a good night’s sleep, especially in a noisy intensive care unit.
Petabytes of data on each patient will become the foundation of future diagnostics and therapy. Genetics, imaging and environmental information – toxins, lifestyle – will deliver a precise picture of the individual, allowing for diagnostic precision and targeted treatments.
